✦ LIBER ✦

Clinical Implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. Population: Insights From the ARIC (Atherosclerosis Risk in Communities) Study

✍ Scribed by Eric Y. Yang; Vijay Nambi; Zhengzheng Tang; Salim S. Virani; Eric Boerwinkle; Ron C. Hoogeveen; Brad C. Astor; Thomas H. Mosley; Josef Coresh; Lloyd Chambless; Christie M. Ballantyne

Book ID: 119268760
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 315 KB
Volume: 54
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2009.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Justification for the use of statins in

Justification for the use of statins in primary prevention: An intervention trial evaluating rosuvastatin (the JUPITER trial)

✍ Nathan D. Wong 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 186 KB

The Cost-Effectiveness of Rosuvastatin T

The Cost-Effectiveness of Rosuvastatin Therapy: JUPITER (Justification for the Use of statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)

✍ Mark Hlatky 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Race, ethnicity, and the efficacy of ros

Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial

✍ Michelle A. Albert; Robert J. Glynn; Francisco A.H. Fonseca; Alberto J. Lorenzat 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Justification for the Use of Statins in

Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)—Can C-Reactive Protein Be Used to Target Statin Therapy in Primary Prevention?

✍ Samia Mora; Paul M. Ridker 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Relation of Baseline High-Sensitivity C-

Relation of Baseline High-Sensitivity C-Reactive Protein Level to Cardiovascular Outcomes With Rosuvastatin in the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)

✍ Paul M. Ridker; Jean MacFadyen; Peter Libby; Robert J. Glynn 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Prevalence of Low Low-Density Lipoprotei

Prevalence of Low Low-Density Lipoprotein Cholesterol With Elevated High Sensitivity C-Reactive Protein in the U.S.: Implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) Study

✍ Erin D. Michos; Roger S. Blumenthal 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 196 KB